Target intelligence / Profile preview

Eukaryotic 80S ribosome aminoacyl-tRNA binding site (A-site) (80S A-site)

Target
80S A-site
Molecular classification
Ribonucleoprotein, Translation machinery, Ribosome
01

Overview

The eukaryotic 80S ribosome A-site (aminoacyl-tRNA binding site) is a fundamental functional region within the protein-synthesizing machinery of eukaryotic cells, comprising components of both the 40S small subunit and the 60S large subunit [2, 5]. It serves as the entry point for aminoacyl-tRNA molecules, where the anticodon of the tRNA is matched against the mRNA codon in the decoding center of the 40S subunit, while the acceptor stem extends into the peptidyl transferase center (PTC) of the 60S subunit [4, 6]. This site is a major target for therapeutic intervention in oncology and genetic medicine [5]. In cancer, inhibitors like homoharringtonine (omacetaxine mepesuccinate) bind to the A-site of the PTC to prevent the correct positioning of aminoacyl-tRNAs, thereby halting translation elongation and inducing apoptosis in rapidly dividing cells [4, 5]. In the context of genetic diseases, specialized molecules such as ELX-02 (NB124) target the A-site decoding center to promote the read-through of premature stop codons, enabling the synthesis of full-length, functional proteins from genes containing nonsense mutations [1, 9]. A critical challenge in drug development for this target is achieving high selectivity for the eukaryotic cytosolic ribosome over the structurally similar bacterial and mitochondrial ribosomes to minimize toxicities like ototoxicity and nephrotoxicity [8, 9].

Other names
Aminoacyl-tRNA binding siteRibosomal A-siteEukaryotic decoding center80S aminoacyl siteA-site of the 80S ribosome
02

Mechanism of action

Inhibition of translation elongation by blocking aminoacyl-tRNA binding or induction of translational read-through of premature stop codons by altering decoding fidelity.

03

Biological functions

Protein synthesisTranslation elongationGenetic decodingAminoacyl-tRNA binding
04

Disease associations

CancerCystic FibrosisNephropathic CystinosisDuchenne Muscular DystrophyGenetic disease
05

Safety considerations

OtotoxicityNephrotoxicityMitochondrial translation inhibitionMyelosuppression
06

Interacting drugs

Omacetaxine mepesuccinate

6 more in the full profile.

07

Biomarkers

CFTR protein expressionp53 protein expressionCystinosin protein expression

Beyond the preview

Go deeper on Eukaryotic 80S ribosome aminoacyl-tRNA binding site (A-site) (80S A-site).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic 80S ribosome aminoacyl-tRNA binding site (A-site) (80S A-site).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call